Foundation Medicine
2
2
0.15
1
- Areas of investment
Summary
Foundation Medicine appeared to be the Corporate Investor, which was created in 2010. The company was established in North America in United States. The leading representative office of defined Corporate Investor is situated in the Cambridge.
The standard case for the fund is to invest in rounds with 6 partakers. Despite the Foundation Medicine, startups are often financed by Med-Metrix, Horizon Healthcare Services, Horizon Blue Cross Blue Shield of New Jersey. The meaningful sponsors for the fund in investment in the same round are Regional Cancer Care Associates, Novartis, Med-Metrix. In the next rounds fund is usually obtained by Boston Millennia Partners, Memorial Sloan - Kettering Cancer Center, IQVIA.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Analytics, Information Services. Among the most popular portfolio startups of the fund, we may highlight Cota Healthcare. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The fund was created by Alexis Borisy.
The important activity for fund was in 2016. The fund is generally included in less than 2 deals every year.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 1
- Rounds per year
- 0.15
- Investments by industry
- Health Care (2)
- Life Science (1)
- Biotechnology (1)
- Investments by region
-
- United States (2)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 25
- Group Appearance index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| COTA Healthcare | 24 May 2016 | Biotechnology, Health Care, Life Science | Early Stage Venture | 0 | United States, New York, New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.